Literature DB >> 20830706

Id3 modulates cellular localization of bHLH Ptf1-p48 protein.

Marlène Dufresne1, Pascal Clerc, Madieng Dieng, Anissa Edir, Anne Couvelard, Marie-Bernadette Delisle, Daniel Fourmy, Véronique Gigoux.   

Abstract

Ptf1-p48 is a pancreas-specific bHLH transcriptional protein, which, in the normal adult pancreas, shows a restricted expression in acinar cells where it is predominantly localized in the nucleus and activates the transcription of exocrine-specific genes. Ptf1-p48 partners with two proteins to form the PTF1 active complex: a bHLH E-protein and suppressor of hairless RBP-J. Cytoplasmic mislocalization of Ptf1-p48 has been reported in pancreatic pathologies, suggesting its contribution in the early steps of pancreatic carcinogenesis. The aim of the our work was to elucidate the mechanisms regulating Ptf1-p48 subcellular localization. We hypothesized a role of Id proteins acting in a dominant-negative fashion by heterodimerizing with bHLH proteins. We reproduced Ptf1-p48 cytoplasmic mislocalization in acinar AR4-2J cells and demonstrated that a proliferative signal elicited by gastrin leads to increases in Id3 protein expression and levels of Id3/E47 and Id3/Ptf1-p48 interactions, and a decrease in the level of E47/Ptf1-p48 interaction. By contrast, Id3 silencing reversed the cytoplasmic mislocalization of Ptf1-p48 induced by gastrin. As E47 is responsible for the nuclear import of the PTF1 complex, disruption of this complex via Id3 interactions with both E47 and Ptf1-p48 appears to induce cytoplasmic mislocalization of Ptf1-p48. We then found that Ptf1-p48 is either absent or mislocalized in the cytoplasm and Id3 is overexpressed in human and murine pancreatic preneoplastic lesions. Our data provide novel insight into the regulation of Ptf1-p48 function and provide evidence that Ptf1-p48 cytoplasmic mislocalization and Id3 overexpression are early events in pancreatic cancer progression.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830706     DOI: 10.1002/ijc.25668

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  The Id3/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma.

Authors:  Seung-Hee Lee; Ergeng Hao; Alice Kiselyuk; James Shapiro; David J Shields; Andrew Lowy; Fred Levine; Pamela Itkin-Ansari
Journal:  Mol Cancer Res       Date:  2011-04-15       Impact factor: 5.852

Review 2.  Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer.

Authors:  Chi-Hin Wong; You-Jia Li; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

3.  The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.

Authors:  SangWun Kim; Reyhaneh Lahmy; Chelsea Riha; Challeng Yang; Brad L Jakubison; Jaco van Niekerk; Claudio Staub; Yifan Wu; Keith Gates; Duc Si Dong; Stephen F Konieczny; Pamela Itkin-Ansari
Journal:  Pancreas       Date:  2015-07       Impact factor: 3.327

4.  Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability.

Authors:  Cornelia Jäkel; Frank Bergmann; Reka Toth; Yassen Assenov; Daniel van der Duin; Oliver Strobel; Thomas Hank; Günter Klöppel; Craig Dorrell; Markus Grompe; Joshua Moss; Yuval Dor; Peter Schirmacher; Christoph Plass; Odilia Popanda; Peter Schmezer
Journal:  Nat Commun       Date:  2017-11-06       Impact factor: 14.919

5.  A screen for inducers of bHLH activity identifies pitavastatin as a regulator of p21, Rb phosphorylation and E2F target gene expression in pancreatic cancer.

Authors:  Nicholas Villarino; Lia Signaevskaia; Jaco van Niekerk; Rachel Medal; Heejung Kim; Reyhaneh Lahmy; Kathleen Scully; Anthony Pinkerton; Sangwun Kim; Andrew Lowy; Pamela Itkin-Ansari
Journal:  Oncotarget       Date:  2017-06-21

6.  E47 Governs the MYC-CDKN1B/p27KIP1-RB Network to Growth Arrest PDA Cells Independent of CDKN2A/p16INK4A and Wild-Type p53.

Authors:  Kathleen M Scully; Reyhaneh Lahmy; Lia Signaevskaia; Roman Sasik; Rachel Medal; Heejung Kim; Randall French; Brian James; Yifan Wu; Andrew M Lowy; Pamela Itkin-Ansari
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-05-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.